Planning to develop novel
therapeutics for neurological
or psychiatric disorders?
We can help
Planning to develop novel
therapeutics for neurological
or psychiatric disorders?
We can help
Connect with Ichnos to access CNS scientific expertise, strategic and technical support.
With extensive experience in developing therapeutics for patients with neurological and psychiatric disorders, we can be the trusted partner you need.
We can complement your existing resources with a tailor made service, or provide full consultancy for your requirements.
We can design and implement regulatory-enabling activities (EMA, FDA, PMDA, NMPA) for First In Human studies, POC and phase 2/3 clinical trials.
We are skilled in evaluation and definition of Target Product Profile (TPP)
Lean on an expert CNS team with specialist know-how in:
CNS Drug Development
Regulatory Affairs
Biotech Start Up
Connect with Ichnos to access CNS scientific expertise, strategic and technical support.
With extensive experience in developing therapeutics for patients with neurological and psychiatric disorders, we can be the trusted partner you need.
We can complement your existing resources with a tailor made service, or provide full consultancy for your requirements.
We can design and implement regulatoryenabling activities (EMA, FDA, PMDA, NMPA) for First In Human studies, POC and phase 2/3 clinical trials.
We are skilled in evaluation and definition of Target Product Profile (TPP).